Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


Gsk Pricing Decision Welcomed

Gsk Pricing Decision Welcomed

PHARMAC has welcomed the decision by GlaxoSmithKline (GSK) to lower the price of its commonly used asthma inhaler fluticasone (Flixotide). The decision means people will be able to continue using this medicine without having to pay a manufacturer’s surcharge.

PHARMAC reference priced fluticasone to the other inhaled corticosteroid drug listed on the Pharmaceutical Schedule, beclomethasone, on 1 February 2003. GSK had been temporarily discounting stock, effectively lowering the price, but has now announced it will reduce the price of fluticasone to the subsidy level.

“This is a good outcome for patients and taxpayers,” says PHARMAC Chief Executive Wayne McNee.

“The decision to reference price fluticasone is forecast to produce savings in the region of $35 million over five years -- $3 million in the June 2003 financial year alone. These are savings that can be used to purchase additional pharmaceuticals or other health services.”

“I welcome this announcement by GSK and look forward to continuing a positive working relationship with them.”

Fluticasone is an inhaled corticosteroid, the main class of drugs used to prevent the onset of asthma symptoms. It is used by over 100,000 New Zealanders.

PHARMAC is also co-ordinating am asthma management campaign, in conjunction with stakeholders including the Asthma and Respiratory Foundation of New Zealand, New Zealand Guidelines Group and the New Zealand College of Pharmacists, to encourage people to self-manage their asthma, and take the correct dose of their asthma medicine.

The campaign is scheduled to run for nine months.

© Scoop Media

Business Headlines | Sci-Tech Headlines


Half A Billion Accounts: Yahoo Confirms Huge Data Breach

The account information may have included names, email addresses, telephone numbers, dates of birth, hashed passwords (the vast majority with bcrypt) and, in some cases, encrypted or unencrypted security questions and answers. More>>

Rural Branches: Westpac To Close 19 Branches, ANZ Looks At 7

Westpac confirms it will close nineteen branches across the country; ANZ closes its Ngaruawahia branch and is consulting on plans to close six more branches; The bank workers union says many of its members are nervous about their futures and asking ... More>>

Interest Rates: RBNZ's Wheeler Keeps OCR At 2%

Reserve Bank governor Graeme Wheeler kept the official cash rate at 2 percent and said more easing will be needed to get inflation back within the target band. More>>


Half Full: Fonterra Raises Forecast Payout As Global Supply Shrinks

Fonterra Cooperative Group, the dairy processor which will announce annual earnings tomorrow, hiked its forecast payout to farmers by 50 cents per kilogram of milk solids as global supply continues to decline, helping prop up dairy prices. More>>



Meat Trade: Silver Fern Farms Gets Green Light For Shanghai Maling Deal

The government has given the green light for China's Shanghai Maling Aquarius to acquire half of Silver Fern Farms, New Zealand's biggest meat company, with ministers satisfied it will deliver "substantial and identifiable benefit". More>>


Get More From Scoop

Search Scoop  
Powered by Vodafone
NZ independent news